Adicet Bio, Inc.
Status: Publicly traded
Direct answer
Adicet Bio, Inc. is publicly traded on NASDAQ under the ticker ACET.
Adicet Bio, Inc. is a biotechnology firm dedicated to pioneering allogeneic gamma delta T cell therapies, aiming to treat cancer and various other diseases. The company’s strategy involves engineering gamma delta T cells with chimeric antigen receptors (CARs) and T cell receptor-like antibodies. This advanced modification is designed to achieve more precise targeting of tumors, enhance the body's natural and...
Can you invest in Adicet Bio, Inc.?
Yes. Adicet Bio, Inc. trades publicly on NASDAQ as ACET.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Adicet Bio, Inc.
Detailed equity research is provided by MarketSnap.